SEC Form 4 · accession 0001179110-18-011431
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip D Worboys
Officer — SVP, Translational Science
Period of report
Sep 12, 2018
Accepted (ET)
Sep 14, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 12, 2018 | S | 6,393 | $28.50 | D | 166,753 | D |
Table II — derivative securities
No Table II lines on this filing.